Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khuri

Showing results (911-920 of 969) with videos related to

Pageof 97
Sort By:
Cancer Medicine|August 16, 2014
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Xingming Deng, et al.
Molecular Cancer Therapeutics|April 22, 2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaNing Jiang, Dongsheng Wang, Zhongliang Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancerRoy S Herbst, Timothy L Madden, Hai T Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2017
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patientsAlice O Kamphorst, Rathi N Pillai, Shu Yang, et al.
Science Translational Medicine|April 22, 2016
A research roadmap for next-generation sequencing informaticsRuss B Altman, Snehit Prabhu, Arend Sidow, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|July 20, 2011
The feasibility of using thermal strain imaging to regulate energy delivery during intracardiac radio-frequency ablationChi Hyung Seo, Douglas N Stephens, Jonathan Cannata, et al.
Vaccine|August 3, 2016
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant womenChristine E Jones, Flor M Munoz, Hans M L Spiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
Cancer Medicine|September 29, 2020
Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancerArafat Tfayli, Majd Al Assaad, Ghina Fakhri, et al.
Pageof 97

Showing results (911-920 of 969) with videos related to

Sort By:
Pageof 97
Cancer Medicine|August 16, 2014
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancerTaofeek K Owonikoko, Guojing Zhang, Xingming Deng, et al.
Molecular Cancer Therapeutics|April 22, 2014
Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinomaNing Jiang, Dongsheng Wang, Zhongliang Hu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor, combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancerRoy S Herbst, Timothy L Madden, Hai T Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2017
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patientsAlice O Kamphorst, Rathi N Pillai, Shu Yang, et al.
Science Translational Medicine|April 22, 2016
A research roadmap for next-generation sequencing informaticsRuss B Altman, Snehit Prabhu, Arend Sidow, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|July 20, 2011
The feasibility of using thermal strain imaging to regulate energy delivery during intracardiac radio-frequency ablationChi Hyung Seo, Douglas N Stephens, Jonathan Cannata, et al.
Vaccine|August 3, 2016
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant womenChristine E Jones, Flor M Munoz, Hans M L Spiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Phase Ib Study of Chemoprevention with Green Tea Polyphenon E and Erlotinib in Patients with Advanced Premalignant Lesions (APL) of the Head and NeckDong M Shin, Sreenivas Nannapaneni, Mihir R Patel, et al.
Cancer Medicine|September 29, 2020
Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancerArafat Tfayli, Majd Al Assaad, Ghina Fakhri, et al.
Pageof 97